|
Coasterphreak posted:Actual answer: the government (FDA specifically) regulates how much can be made annually, the problem is that it’s not keeping up with the rate at which it’s prescribed and drug companies aren’t in a hurry to increase production because it’s all generic now. It goes: - FDA estimates how much Adderall will be need each year - DEA makes up a maximum production yearly based on that - DEA allocates some, but not all of that, to manufactures - Manufacturers may produce up to their quota, but not more than that - There is a process for requesting more quota and relinquishing unused quota quota, but no real consequence for not making everything allocated Manufacturers are incentivized to grab as much quota as they can get just in case, even if they probably won't use it, but DEA assumes that everything they allow is actually produced. Some of the big generic manufacturers (who only make generic drugs, so this isn't a patent vs not thing) have said they requested quota increases but were denied. The DEA's claim is that the shortage isn't their fault because actual production is significantly less than authorized production.
|
#
¿
Feb 20, 2024 01:51
|
|
|
|
| # ¿ May 18, 2024 09:33 |
|